
If you are a believer in resveratrol, then you may be interested in investing in SIRT. Sirtris Pharmaceuticals was co-founded by Harvard University professor David Sinclair, who believes he has found an elixir of youth with resveratrol.
Sinclair thinks resveratrol works by activating SIRT1, a gene that many scientists believe plays a fundamental role in regulating life span in animals. Biologists have found that increasing the expression of SIRT1 slows aging and fends off maladies associated with growing old, including cancer and heart disease. If Sinclair is right, and resveratrol can activate SIRT1–and if the gene does in fact help control aging–he has found something truly remarkable.
…In a 2004 Science interview, Sinclair added to his reputation as a zealot, calling resveratrol “as close to a miraculous molecule as you can find.” “One hundred years from now,” he said, “people will maybe be taking these molecules on a daily basis to prevent heart disease, stroke, and cancer.”
It is interesting to note that his grandmother has eaten human flesh and was the first person to wear a bikini on a beach in Sydney.
SIRT has also “developed a supercharged version of resveratrol, called SRT501″ and claims to have discovered molecules that are “a thousand times as potent in activating the sirtuins.”
“This will impact humans within a decade,” he says. “That’s why I don’t think there is anything more important than this quest. That’s why I take chances, and why the controversy is worth it: because I think we are right.”